Table II.
CXCR1 expression and tumor status.
| Characteristic | No expression (n=24), n (%) | Weak expression (n=46), n (%) | Strong expression (n=13), n (%) | P-value |
|---|---|---|---|---|
| Male:female | 18:6 | 34:12 | 9:4 | P>0.05 |
| Age (years) | 55.6±24.6 | 52.3±20.0 | 56.0±27.3 | P>0.05 |
| Cancer cell differentiation | P>0.05 | |||
| Good | 7 (29.2) | 11 (23.9) | 3 (23.1) | |
| Moderate | 5 (20.8) | 15 (32.6) | 4 (30.8) | |
| Poor | 12 (50.0) | 20 (43.5) | 6 (46.1) | |
| T stage | P<0.05a | |||
| T1 | 4 (16.7) | 1 (2.2) | 0 (0.0) | |
| T2 | 7 (29.2) | 9 (19.6) | 1 (7.7) | |
| T3 | 11 (45.8) | 25 (54.3) | 8 (61.5) | |
| T4 | 2 (8.3) | 11 (23.9) | 4 (30.8) | |
| N stage | P<0.05a | |||
| N0 | 13 (54.2) | 12 (26.1) | 1 (7.7) | |
| N1 | 8 (33.3) | 16 (34.8) | 0 (0.0) | |
| N2 | 2 (8.3) | 14 (30.4) | 2 (15.4) | |
| N3 | 1 (4.2) | 4 (8.7) | 10 (76.9) | |
| Overall stage | P<0.05a | |||
| IA, IB | 7 (29.2) | 3 (6.5) | 0 (0.0) | |
| II | 14 (58.3) | 24 (52.2) | 1 (7.7) | |
| IIIA | 2 (8.3) | 14 (30.4) | 1 (7.7) | |
| IIIB, IIIC and IV | 1 (4.2) | 5 (10.9) | 11 (84.6) |
a
P<0.05 by Spearman correlation.